These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35791668)

  • 1. Treatment patterns of anti-tumour necrosis factor-alpha and prognosis of paediatric and adult-onset inflammatory bowel disease in Korea: a nationwide population-based study.
    Choe YJ; Han K; Shim JO
    Aliment Pharmacol Ther; 2022 Sep; 56(6):980-988. PubMed ID: 35791668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of psoriasiform diseases secondary to tumour necrosis factor antagonists in patients with inflammatory bowel disease: a nationwide population-based cohort study.
    Bae JM; Lee HH; Lee BI; Lee KM; Eun SH; Cho ML; Kim JS; Park JM; Cho YS; Lee IS; Kim SW; Choi H; Choi MG
    Aliment Pharmacol Ther; 2018 Jul; 48(2):196-205. PubMed ID: 29869804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
    Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C
    Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in the epidemiology of inflammatory bowel disease in Colombia by demographics and region using a nationally representative claims database and characterization of inflammatory bowel disease phenotype in a case series of Colombian patients.
    Juliao-Baños F; Kock J; Arrubla M; Calixto O; Camargo J; Cruz L; Hurtado J; Clavijo A; Donado J; Schwartz S; Abreu MT; Damas OM
    Medicine (Baltimore); 2021 Feb; 100(7):e24729. PubMed ID: 33607817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors for the Occurrence and Severity of Vertebral Fractures in Inflammatory Bowel Disease Patients: A Nationwide Population-Based Cohort Study.
    Choi A; Jung SH; Kim S; Lee JS
    J Korean Med Sci; 2023 Jul; 38(28):e210. PubMed ID: 37463684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent trends in the epidemiology and clinical outcomes of inflammatory bowel disease in South Korea, 2010-2018.
    Kim S; Lee HJ; Lee SW; Park S; Koh SJ; Im JP; Kim BG; Han KD; Kim JS
    World J Gastroenterol; 2024 Mar; 30(9):1154-1163. PubMed ID: 38577186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of antitumour necrosis factor therapy on surgery in inflammatory bowel disease: a population-based study.
    Hawthorne AB; Arms-Williams B; Cannings-John R; Pollok RCG; Berry A; Harborne P; Trivedi A
    BMJ Open Gastroenterol; 2024 May; 11(1):. PubMed ID: 38777566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Risk of Cancer and Mortality in a Large French Population-Based Paediatric-Onset Inflammatory Bowel Disease Retrospective Cohort.
    Dupont-Lucas C; Leroyer A; Ley D; Spyckerelle C; Bertrand V; Turck D; Savoye G; Maunoury V; Guillon N; Fumery M; Sarter H; Gower-Rousseau C;
    J Crohns Colitis; 2023 Apr; 17(4):524-534. PubMed ID: 36316987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of Immune-Mediated Inflammatory Diseases Among Patients With Inflammatory Bowel Diseases in Denmark.
    Burisch J; Jess T; Egeberg A
    Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2704-2712.e3. PubMed ID: 30936024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Disease Phenotype and Course among Elderly- and Early-Onset Inflammatory Bowel Diseases in the Middle East.
    Vosoghinia H; Saberzadeh-Ardestani B; Anushiravani A; Mansour-Ghanaei F; Fakheri H; Vahedi H; Sheikhesmaeili F; Yazdanbod A; Moosavy SH; Maleki I; Nasseri-Moghaddam S; Khosravi B; Malekzadeh M; Kasaeian A; Alatab S; Sadeghi A; Kolahdoozan S; Amani M; Saberhosseini SN; Rayatpisheh M; Ahadi M; Colombel JF; Ungaro RC; Sima AR; Malekzadeh R
    Arch Iran Med; 2023 Sep; 26(9):481-488. PubMed ID: 38310403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: a meta-analysis.
    Billioud V; Ford AC; Tedesco ED; Colombel JF; Roblin X; Peyrin-Biroulet L
    J Crohns Colitis; 2013 Dec; 7(11):853-67. PubMed ID: 23523418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Rising Burden of Inflammatory Bowel Disease in Denmark Over Two Decades: A Nationwide Cohort Study.
    Agrawal M; Christensen HS; Bøgsted M; Colombel JF; Jess T; Allin KH
    Gastroenterology; 2022 Dec; 163(6):1547-1554.e5. PubMed ID: 35952799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indicators of suboptimal response to anti-tumor necrosis factor therapy in patients from China with inflammatory bowel disease: results from the EXPLORE study.
    Li J; Liu Z; Hu P; Wen Z; Cao Q; Zou X; Chen Y; Wang Y; Zhong J; Shen X; Demuth D; Fadeeva O; Xie L; Chen J; Qian J
    BMC Gastroenterol; 2022 Feb; 22(1):44. PubMed ID: 35120446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic management of inflammatory bowel disease in real-life practice in the current era of anti-TNF agents: analysis of the French administrative health databases 2009-2014.
    Kirchgesner J; Lemaitre M; Rudnichi A; Racine A; Zureik M; Carbonnel F; Dray-Spira R
    Aliment Pharmacol Ther; 2017 Jan; 45(1):37-49. PubMed ID: 27781286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Features and Long-Term Outcomes of Paediatric-Onset Inflammatory Bowel Disease in a Population-Based Cohort in the Songpa-Kangdong District of Seoul, Korea.
    Park SH; Im JP; Park H; Jeong SK; Lee JH; Rhee KH; Kim YH; Hong SN; Kim KH; Seo SI; Cha JM; Park SY; Kim JS; Yoon H; Kim SH; Jang J; Kim JH; Suh SO; Kim YK; Ye BD; Yang SK
    J Crohns Colitis; 2022 Feb; 16(2):207-215. PubMed ID: 34309652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased risk of genital warts in inflammatory bowel disease: A Danish registry-based cohort study (1996-2018).
    Elmahdi R; Thomsen LT; Iversen AT; Allin KH; Kjaer SK; Jess T
    United European Gastroenterol J; 2022 Apr; 10(3):287-295. PubMed ID: 35297191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of dementia in patients with inflammatory bowel disease: a Danish population-based study.
    Rønnow Sand J; Troelsen FS; Horváth-Puhó E; Henderson VW; Sørensen HT; Erichsen R
    Aliment Pharmacol Ther; 2022 Sep; 56(5):831-843. PubMed ID: 35781292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of inflammatory bowel disease with steroid-sparing medications is age-dependent - Results from a Danish nationwide cohort study, 2000-2018.
    Nordestgaard RLM; Wewer MD; Malham M; Wewer V; Boysen T; Burisch J
    Aliment Pharmacol Ther; 2024 Aug; 60(4):457-468. PubMed ID: 38859674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-life efficacy of vedolizumab on endoscopic healing in inflammatory bowel disease - A nationwide Hungarian cohort study.
    Bor R; Fábián A; Matuz M; Szepes Z; Farkas K; Miheller P; Szamosi T; Vincze Á; Rutka M; Szántó K; Bálint A; Nagy F; Milassin Á; Tóth T; Zsigmond F; Bajor J; Müllner K; Lakner L; Papp M; Salamon Á; Horváth G; Sarang K; Schäfer E; Sarlós P; Palatka K; Molnár T
    Expert Opin Biol Ther; 2020 Feb; 20(2):205-213. PubMed ID: 31782939
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.